FDA to review use of Amitiza for IBS

09/19/2007 | CNNMoney

The FDA is considering an additional approval for the chronic constipation drug Amitiza as a treatment for irritable bowel syndrome with constipation in an 8-microgram dose. The agency is expected to issue a decision in the second quarter of 2008.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI